Exelixis reported $83.24M in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Agios Pharmaceuticals AGIO:US $ -101145000 3.68M
Akebia Therapeutics AKBA:US $ -58493000 7.66M
Amgen AMGN:US $ 2500M 196M
AstraZeneca AZN:LN 2.88B 1.57B
Bayer BAYN:GR 4.17B 704M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bluebird Bio BLUE:US $ -120346000 138.95M
Bristol Myers Squibb BMY:US $ 3188M 399M
Cytokinetics CYTK:US $ -77857000 58.95M
Eisai 4523:JP -20803000000 34.45B
Eli Lilly And LLY:US $ 2569.9M 171.6M
Esperion Therapeutics ESPR:US $ -42989000 611K
Exelixis EXEL:US $ 83.24M 33.4M
Genmab GEN:DC 514M 295M
Glaxosmithkline GSK:US 2.42B 724M
Immunogen IMGN:US $ -22852000 11.7M
IONIS PHARMACEUT IONS:US $ -57504000 278.11M
Macrogenics MGNX:US $ -66638000 8.4M
Merk MRK:US $ 5059M 207M
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Moderna Inc MRNA:US 4.23B 1.18B
Nektar Therapeutics NKTR:US $ -115085000 2.17M
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Novartis NOVN:VX 3.15B 266M
Pfizer PFE:US $ 9995M 4136M
Puma Biotechnology PBYI:US $ -747000 7.58M
Seattle Genetics SGEN:US $ -133050000 39.02M
Takeda 4502:JP -1619000000 144.87B
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
Xencor XNCR:US $ 26.47M 65.19M
YTE INCY:US $ 127.66M 7.71M